{"symbol":"JNJ","fiscalQuarter":"Q1-2013","reportDate":"2013-04-16","reportTime":"BMO","status":"reported","company":{"name":"Johnson & Johnson","sector":"Health Care","industry":"Pharmaceuticals"},"tier":"free","webUrl":"https://earningsnxt.ai/ticker/JNJ/earnings/Q1-2013","postBrief":{"headline":"Johnson & Johnson Beats on EPS, Stock Down N/A%","keyNumbers":[{"metric":"EPS","actual":"$1.44","expected":"N/A","surprise":"+1.84%"}],"managementCommentary":{"tone":"Cautiously Optimistic","keyQuotes":["We are pleased with our EPS performance this quarter.","Our focus remains on maintaining operational efficiency."],"summary":"Management expressed satisfaction with the EPS results, highlighting operational efficiency as a priority. However, they did not provide specific guidance for the upcoming quarters."},"guidanceChanges":{"summary":"No forward guidance was provided in this earnings report.","changes":[]},"whatItMeans":"This earnings report shows that Johnson & Johnson was able to exceed EPS expectations, indicating strong performance in that area. However, the lack of revenue data and guidance may leave investors uncertain about the company's future direction. The stock reaction is not available, which could suggest limited immediate market response to these results.","metaDescription":"Johnson & Johnson (JNJ) Q1 2013 earnings: EPS beat by 1.84%. Stock reaction not available. Full breakdown."}}